SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

Search

EssilorLuxottica SA

Uždarymo kaina

SektoriusSveikatos priežiūra

243.1 -0.29

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

242.9

Max

243.6

Pagrindiniai rodikliai

By Trading Economics

Pajamos

993M

Pardavimai

13B

P/E

Sektoriaus vid.

47.432

39.857

Dividendų pajamingumas

1.7

Pelno marža

7.512

Darbuotojai

153,498

EBITDA

3.6B

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+9.78% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.70%

2.42%

Kitas uždarbis

2025-07-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-8.8B

112B

Ankstesnė atidarymo kaina

243.39

Ankstesnė uždarymo kaina

243.1

Naujienos nuotaikos

By Acuity

37%

63%

119 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

EssilorLuxottica SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-09 06:54; UTC

Įsigijimai, susijungimai, perėmimai

Meta Bought Minority Stake in Ray-Ban Maker EssilorLuxottica, Bloomberg Says, Citing Sources

2025-05-30 06:42; UTC

Įsigijimai, susijungimai, perėmimai

Ray-Ban Maker EssilorLuxottica to Buy Optegra in Medical AI Push

2025-04-23 18:17; UTC

Uždarbis

Ray-Ban Maker EssilorLuxottica Implements Measures to Weather U.S. Tariffs -- Update

2025-04-23 16:36; UTC

Uždarbis

Ray-Ban Maker EssilorLuxottica to Implement Measures to Mitigate U.S. Tariffs

2025-07-11 10:36; UTC

Rinkos pokalbiai

Luxury Sector Unlikely to Report Positive Prints -- Market Talk

2025-07-09 14:31; UTC

Įsigijimai, susijungimai, perėmimai

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

2025-07-09 12:25; UTC

Įsigijimai, susijungimai, perėmimai

Meta Wants to Reboot the Metaverse. Why AI Glasses Could Hold the Key. -- Barrons.com

2025-07-09 07:21; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Meta's Reported EssilorLuxottica Investment Seen as Vote of Confidence -- Market Talk

2025-07-02 15:08; UTC

Rinkos pokalbiai

Luxury Sector Should Report a Slowdown -- Market Talk

2025-07-01 11:26; UTC

Rinkos pokalbiai

Luxury Sector Expected to Remain Subdued -- Market Talk

2025-07-01 11:12; UTC

Rinkos pokalbiai

Luxury Industry Faces Deceleration as Tourism Slows -- Market Talk

2025-06-30 12:07; UTC

Rinkos pokalbiai

EssilorLuxottica Expected to Report Growth Across All Regions -- Market Talk

2025-06-05 06:04; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Doesn't Release Financial Details

2025-06-05 06:03; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Transaction Is Expected to Close by the End of June

2025-06-05 06:03; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: A-Look Operates Over 90 Stores Under A-Look, Seen and OWL Banners

2025-06-05 06:02; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Deal Aimed Complementing Long-Standing Position in Malaysia

2025-06-05 06:00; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica to Buy A-Look, Seen and OWL Retail Stores in Malaysia

2025-05-30 08:58; UTC

Karštos akcijos

Stocks to Watch Friday: Dell, Marvell, Gap, Ulta -- WSJ

2025-05-30 06:04; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Deal to Close in 2025 Pending Approvals, Customary Closing Conditions

2025-05-30 06:03; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Doesn't Disclose Financial Details

2025-05-30 06:02; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Acquisition Is Part of Med-Tech Strategy

2025-05-30 06:01; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica to Buy Ophthalmology Platform Optegra Clinics

2025-05-30 06:00; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica to Buy Optegra Clinics

2025-04-24 09:58; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica's Main Challenge Is Trade Environment -- Market Talk

2025-04-24 09:35; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica's Results Show Resilience Given Macroeconomic Woes -- Market Talk

2025-04-24 08:11; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica Shows Resilience, But Market Might Turn Cautious -- Market Talk

2025-04-03 08:00; UTC

Rinkos pokalbiai

European Luxury Companies Fall After Tariffs; Profit Margins Expected to Shrink -- Market Talk

2025-03-28 08:57; UTC

Rinkos pokalbiai

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

2025-02-13 11:05; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

2025-02-13 10:54; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

Akcijų palyginimas

Kainos pokytis

EssilorLuxottica SA Prognozė

Kainos tikslas

By TipRanks

9.78% į viršų

12 mėnesių prognozė

Vidutinis 268.09 EUR  9.78%

Aukščiausias 300 EUR

Žemiausias 240 EUR

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines EssilorLuxottica SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

12 ratings

7

Pirkti

5

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

243.3 / 250.9Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

119 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.